Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS

Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS

Item
http://www.wikidata.org/entity/Q35179832
Primary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectivesNeuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting.Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.Restimulation-induced cell death: new medical and research perspectives.A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1-T146.Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.The Future of Immunotherapy: A 20-Year Perspective.Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-ContrAn antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.Engineered T Regulatory Type 1 Cells for Clinical Application.Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis.Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis.ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs.
P2860

Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS

Item
http://www.wikidata.org/entity/Q35179832
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
@ast
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
@en
type
label
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
@ast
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
@en
prefLabel
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
@ast
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
@en
P2093
P2860
P304
P31
P356
10.1212/NXI.0000000000000093
P433
P478
P50
P577
P698
P932